Research on Alveolar Type Ⅱ Epithelial Cell Senescence in Idiopathic Pulmonary FibrosisOA
Idiopathic pulmonary fibrosis(IPF)is an age-associated,progressive fibrotic interstitial lung disease with limited disease-modifying therapies and poor long-term outcomes.Increasing evidence indicates that senescence of alveolar type II epithelial(AT2)cells is not merely a bystander phenomenon but a central driver of epithelial dysfunction,failed alveolar regeneration,and fibrotic remodeling.In this narrative review,we summarize recent mechanistic,single-cell,epigenetic,and translational studies that have reshaped the epithelial-centered model of IPF.We first outline normal AT2 biology and the regenerative AT2-to-AT1 trajectory,and then discuss how telomere dysfunction,endoplasmic reticulum stress,mitochondrial injury,DNA damage signaling,and aberrant mechanotransduction promote AT2 senescence.We further examine how senescence-associated secretory phenotype(SASP),maladaptive transitional epithelial states,and epithelial-stromal crosstalk sustain fibrosis.Finally,we review emerging therapeutic approaches,including senolytics,senomorphics,pathway-directed interventions,and RNA or epigenetic strategies,while emphasizing current limitations in model systems,biomarker development,delivery,safety,and patient stratification.Together,the available evidence supports AT2 senescence as a pathogenic and potentially targetable axis in IPF.
Lichun Zhong;Dijia Wu;Sirui Zhang;Wenjing Liu;Faping Wang;Fengming Luo
Laboratory of Pulmonary Immunology and Inflammation,Frontiers Science Center for Disease-related Molecular Network,West China Hospital,Sichuan University,Chengdu,ChinaWest China School of Clinical Medicine,West China Hospital,Sichuan University,Chengdu,ChinaWest China School of Clinical Medicine,West China Hospital,Sichuan University,Chengdu,ChinaWest China School of Clinical Medicine,West China Hospital,Sichuan University,Chengdu,ChinaDepartment of Pulmonary and Critical Care Medicine,West China Hospital,Sichuan University,Chengdu,ChinaDepartment of Pulmonary and Critical Care Medicine,West China Hospital,Sichuan University,Chengdu,China
医药卫生
Idiopathic pulmonary fibrosisalveolar type II epithelial cellscellular senescencesignaling pathwaysanti-senescence therapy
《BIOCELL》 2026 (9)
P.79-97,19
supported by the National Natural Science Foundation of China grant(NSFC No.82400084)the Sichuan Science and Technology Program(No.2024NSFSC1530).
评论